Kallyope, based in the Alexandria Center for Life Science in New York City, secured $112 million in a Series C financing round that will be used to advance the company’s gut-brain axis field-focused programs into clinical trials.
https://www.pharmalive.com/wp-content/uploads/2020/03/Kallyope-112-Million-Financing-Round-BioSpace-3-25-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-03-25 12:49:072020-03-30 00:42:23Kallyope Prepares to Enter Clinic Following $112 Million Financing Round